NCT02636244View on ClinicalTrials.gov

Safety and Efficacy Study of SHAPE Gel in Alopecia Areata

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

August 31, 2017

Study Completion Date

January 31, 2018

Conditions
Alopecia Areata
Interventions
DRUG

SHAPE Gel

Sponsors
All Listed Sponsors
lead

TetraLogic Pharmaceuticals

INDUSTRY

NCT02636244 - Safety and Efficacy Study of SHAPE Gel in Alopecia Areata | Biotech Hunter | Biotech Hunter